Cargando…
Pulmonary Mucormycosis as the Leading Clinical Type of Mucormycosis in Western China
The aim was to better understand the clinical characteristics of patients with mucormycosis in western China. We retrospectively investigated the clinical, laboratory, radiological and treatment profiles of mucormycosis patients during a 10-year period (2010–2019). As a result, 59 proven mucormycosi...
Autores principales: | Qu, Junyan, Liu, Xijiao, Lv, Xiaoju |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645928/ https://www.ncbi.nlm.nih.gov/pubmed/34881195 http://dx.doi.org/10.3389/fcimb.2021.770551 |
Ejemplares similares
-
Editorial: Research advances in mucormycosis
por: Singh, Rachna
Publicado: (2023) -
Amphotericin B colloidal dispersion: an effective drug for the treatment of mucormycosis in China
por: Liu, Juntao, et al.
Publicado: (2023) -
Mucormycosis in 2023: an update on pathogenesis and management
por: Alqarihi, Abdullah, et al.
Publicado: (2023) -
Recent Advances and Future Directions in the Understanding of Mucormycosis
por: Garre, Victoriano
Publicado: (2022) -
Mucormycosis in the COVID-19 Environment: A Multifaceted Complication
por: Sharma, Rohit, et al.
Publicado: (2022)